Status:
COMPLETED
Effect of Combined Use of Ivermectin and Colchicine in COVID-19 Patients
Lead Sponsor:
Ain Shams University
Conditions:
COVID-19
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
The aim of this study will be to investigate the efficacy of use of combination of Ivermectin and colchicine on severity and outcome Of COVID 19 infection.
Eligibility Criteria
Inclusion
- Willing and able to provide written informed consent prior to performing study procedures.
- Currently hospitalized and requiring medical care for non-sever COVID-19.
- One or more of the following: (positive PCR test or positive antibodies) or (CT Chest consistent with COVID19 infection).
Exclusion
- Tocilizumab use.
- Mechanical ventilation
- Requirement of oxygen supplementation \>8L/min on admission
Key Trial Info
Start Date :
November 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2022
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT05246072
Start Date
November 1 2021
End Date
February 28 2022
Last Update
April 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University hospitals
Cairo, Egypt, 11591